United States

China National Medicines Corp Ltd (600511.SS)

600511.SS on Shanghai Stock Exchange

14 Feb 2018
Change (% chg)

¥-0.04 (-0.14%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Chart for


China National Medicines Corporation Ltd. is a China-based company principally engaged in the distribution of pharmaceutical products. The Company's primary products include proprietary Chinese medicines, chemical medicine preparations, chemical raw materials, antibiotics, biochemical drugs, biological products, narcotic drugs,... (more)


Beta: 0.82
Market Cap(Mil.): ¥22,110.70
Shares Outstanding(Mil.): 766.93
Dividend: 0.20
Yield (%): 0.69


  Industry Sector
P/E (TTM): -- 20.16 17.27
EPS (TTM): -- -- --
ROI: -- 11.61 35.43
ROE: -- 13.76 17.10

BRIEF-China National Medicines Says Board Elects Jiang Xiuchang As Chairman

* SAYS BOARD ELECTS JIANG XIUCHANG AS CHAIRMAN Source text in Chinese: http://bit.ly/2BGnTIq Further company coverage: (Reporting by Hong Kong newsroom)

Feb 06 2018

BRIEF-China National Medicines Expects 2017 Net Profit To Rise 100-120 Percent Y/Y

* SAYS IT EXPECTS 2017 NET PROFIT TO RISE 100-120 PERCENT Y/Y VERSUS 547.6 MILLION YUAN ($86.56 million)YEAR AGO Source text in Chinese: http://bit.ly/2DHEcBL Further company coverage: ($1 = 6.3265 Chinese yuan renminbi) (Reporting by Hong Kong newsroom)

Jan 29 2018

BRIEF-China National Medicines elects chairman

* SAYS BOARD ELECTS JIANG XIUCHANG AS CHAIRMAN, REPLACING LIU YONG Source text in Chinese: http://bit.ly/2BWadoE Further company coverage: (Reporting by Hong Kong newsroom)

Dec 12 2017

BRIEF-China National Medicines' 9-month net profit up 9.1 pct y/y

* Says 9-month net profit up 9.1 percent y/y a t 835.8 million yuan ($125.83 million)

Oct 25 2017

BRIEF-China National Medicines Corp to provide loan of up to 400 mln yuan to controlling bio-medicine unit

* Says it plans to provide loan of up to 400 million yuan to Beijing-based controlling biological medicine subsidiary

Aug 22 2017

BRIEF-China National Medicines' H1 net profit up 10.8 pct y/y

* Says H1 net profit up 10.8 percent y/y at 553.9 million yuan ($83.14 million)

Aug 22 2017

Earnings vs. Estimates